CSIMarket
 


Nutriband Inc   (NTRB)
Other Ticker:  
 

Nutriband Inc 's Leverage Ratio

NTRB's quarterly Leverage Ratio and Total Liabilities, Equity growth




NTRB Leverage Ratio (Oct 31 2022)
III. Quarter
(Jul 31 2022)
I. Quarter
(Apr 30 2022)
I. Quarter
(Oct 31 2021)
III. Quarter
(Jul 31 2021)
II. Quarter
Y / Y Equity Change 33.02 % 32.74 % 55.8 % 97.39 % 464.23 %
Y / Y Total Liabilities Change -67.86 % -64.22 % -68.81 % -64.21 % 212.63 %
Leverage Ratio MRQ 0.09 0.09 0.08 0.07 0.39
Overall Ranking # 212 # 0 # 0 # 252 #
Seq. Equity Change -6.44 % -6.12 % -22.62 % 95.72 % -6.64 %
Seq. Total Liabilities Change -6.08 % 10.94 % -13.2 % -64.46 % 4.56 %



Leverage Ratio third quarter 2022 Comment
Due to repayements of liabilities of -6.08% Nutriband Inc improved Leverage Ratio in third quarter 2022 to 0.09, below company's average Leverage Ratio.

Within Biotechnology & Pharmaceuticals industry in the third quarter 2022, 24 other companies have achieved lower Leverage Ratio than Nutriband Inc . While Leverage Ratio total ranking has deteriorated compare to the previous quarter from 0 to 212.

Explain Leverage Ratio?
Who are NTRB Customers?
Leverage Ratio third quarter 2022 Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry # 25
Healthcare Sector # 118
Overall Market # 212


Leverage Ratio Statistics
High Average Low
11.53 0.95 0.06
(Jan 31 2020)   (Jul 31 2018)




Financial Statements
Nutriband Inc 's Equity $ 10 Millions Visit NTRB's Balance sheet
Nutriband Inc 's Total Liabilities $ 1 Millions Visit NTRB's Balance sheet
Source of NTRB's Sales Visit NTRB's Sales by Geography


Cumulative Nutriband Inc 's Leverage Ratio

NTRB's Leverage Ratio for the trailling 12 Months

NTRB Leverage Ratio

(Oct 31 2022)
III. Quarter
(Jul 31 2022)
I. Quarter
(Apr 30 2022)
I. Quarter
(Oct 31 2021)
III. Quarter
(Jul 31 2021)
II. Quarter
Y / Y Equity TTM Growth 33.02 % 32.74 % 55.8 % 97.39 % 464.23 %
Y / Y Total Liabilities TTM Growth -67.86 % -64.22 % -68.81 % -64.21 % 212.63 %
Leverage Ratio TTM 0.08 0.13 0.18 0.25 0.38
Total Ranking TTM # 193 # 379 # 514 # # 621
Seq. Equity TTM Growth -6.44 % -6.12 % -22.62 % 95.72 % -6.64 %
Seq. Total Liabilities TTM Growth -6.08 % 10.94 % -13.2 % -64.46 % 4.56 %


TTM Leverage Ratio Comment
On the trailing twelve months basis Due to repayements of liabilities of -6.08% Nutriband Inc decreased Leverage Ratio in the III. Quarter to 0.08, below company's average Leverage Ratio.
Leverage Ratio is the average cumulative value over the last four quarters.

Among companies in the Biotechnology & Pharmaceuticals industry 19 other companies have achieved lower Leverage Ratio than Nutriband Inc . While Leverage Ratio total ranking has improved so far to 191, from total ranking in previous quarter at 358.

Explain Leverage Ratio?
Who are NTRB Customers?

TTM Leverage Ratio Company Ranking
Within: No.
Within the Biotechnology & Pharmaceuticals Industry # 20
Healthcare Sector # 108
Within the Market # 193


TTM Leverage Ratio Statistics
High Average Low
1.25 0.47 0.09
(Jul 31 2020)   (Oct 31 2022)




Companies with similar Leverage Ratio in the quarter ending Oct 31 2022, within Biotechnology & Pharmaceuticals Industry Leverage RatioOct 31 2022 MRQ Total LiabilitiesOct 31 2022 MRQ Equity
Vir Biotechnology Inc   0.25 $ 546.115  Millions$ 2,149.855  Millions
Aura Biosciences Inc   0.24 $ 28.093  Millions$ 115.054  Millions
Jasper Therapeutics Inc   0.24 $ 11.545  Millions$ 47.565  Millions
Caribou Biosciences Inc   0.23 $ 74.709  Millions$ 324.114  Millions
Bio techne Corp  0.23 $ 402.290  Millions$ 1,751.154  Millions
Monte Rosa Therapeutics Inc   0.23 $ 66.511  Millions$ 291.092  Millions
Iteos Therapeutics Inc   0.23 $ 143.674  Millions$ 634.199  Millions
Jounce Therapeutics inc   0.22 $ 28.723  Millions$ 129.358  Millions
Aptose Biosciences Inc   0.21 $ 9.964  Millions$ 46.814  Millions
Revolution Medicines Inc   0.21 $ 144.491  Millions$ 681.419  Millions
Dyadic International Inc  0.21 $ 2.607  Millions$ 12.612  Millions
Crispr Therapeutics Ag  0.20 $ 399.402  Millions$ 1,953.954  Millions
Passage Bio inc   0.20 $ 45.656  Millions$ 224.396  Millions
Fate Therapeutics Inc   0.20 $ 103.938  Millions$ 518.003  Millions
Ikena Oncology Inc   0.20 $ 31.680  Millions$ 158.788  Millions
Allogene Therapeutics Inc   0.20 $ 147.611  Millions$ 739.961  Millions
Exelixis Inc   0.19 $ 469.970  Millions$ 2,491.402  Millions
Iovance Biotherapeutics inc   0.19 $ 73.074  Millions$ 393.736  Millions
Surrozen Inc   0.18 $ 13.943  Millions$ 77.491  Millions
Ocugen Inc   0.18 $ 16.729  Millions$ 95.303  Millions
10x Genomics Inc   0.17 $ 132.582  Millions$ 775.792  Millions
Relay Therapeutics Inc   0.17 $ 168.949  Millions$ 999.769  Millions
Tarsus Pharmaceuticals Inc   0.17 $ 33.838  Millions$ 202.627  Millions
Cytek Biosciences Inc   0.16 $ 68.460  Millions$ 416.509  Millions
Allovir Inc   0.16 $ 40.472  Millions$ 253.226  Millions
Intellia Therapeutics Inc   0.16 $ 131.132  Millions$ 824.951  Millions
Bioatla Inc   0.16 $ 22.327  Millions$ 142.634  Millions
Tenaya Therapeutics Inc   0.15 $ 29.982  Millions$ 196.328  Millions
Intuitive Surgical Inc   0.15 $ 1,745.400  Millions$ 11,574.000  Millions
Bionano Genomics Inc   0.15 $ 41.956  Millions$ 281.742  Millions

Date modified: 2022-12-05T00:34:49+00:00

Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

NVS's Profile

Stock Price

NVS's Financials

Business Description

Fundamentals

Charts & Quotes

NVS's News

Suppliers

NVS's Competitors

Customers & Markets

Economic Indicators

NVS's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Largest Companies

Management Effectivness

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Cryptocurrencies

Sectors & Industries

Commodities

Currencies

News


At a Glance

Stocks

Economy

Industries

Other

Help


Sitemap

Advertise

About us

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2023 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071